COVID-19 Infection in Vaccinated Healthcare Professionals

被引:2
作者
Ullah, Muneeb [1 ]
Mubashir, Muaz [2 ]
Atique, Hassan [2 ]
Aslam, Farhan [2 ]
Tahir, Musfirah [3 ]
Naqvi, Mehdi [2 ]
机构
[1] Maroof Int Hosp, Gen Surg, Islamabad, Pakistan
[2] Fed Govt Polyclin Hosp, Internal Med, Islamabad, Pakistan
[3] Maroof Int Hosp, Paediat, Islamabad, Pakistan
关键词
healthcare workers; breakthrough infections; healthcare professionals; covid-19; vaccination; covid; 19; infection;
D O I
10.7759/cureus.23386
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There are different types of Coronavirus disease (COVID-19) vaccines available presently, and their emergency use has been approved by WHO worldwide on a mass scale. COVID-19 vaccine breakthrough infections have been reported worldwide. In Pakistan, there are limited data on COVID-19 vaccine breakthrough infections and their clinical course, especially in healthcare professionals (HCPs). Our study aims to investigate COVID-19 infections among vaccinated HCPs. Methods: A prospective study was conducted on 425 healthcare professionals. Data collected from healthcare professionals included names, age, gender, number of vaccination doses, COVID-19 infection pre and post-vaccination, the severity of COVID-19 infection (if positive), and co-morbid conditions. Ethical board approval was taken. Statistical Package for Social Sciences (SPSS) version 23 (IBM Corp., Armonk, NY) was used to analyze the data. Results: After complete vaccination, 17.27% acquired COVID-19 infection; 2.47% had COVID-19 infection both pre and post-vaccination. The mean age was 32.46 years (n=71) with a standard deviation of +/- 9.376. The male to female ratio was 1.53. COVID-19 PCR was positive in 95.77%. During the course of the disease, 4.2% were asymptomatic, 92.95% had mild symptoms, 1.4% were hospitalized, and 1.4% had to be managed in the intensive care unit. None of the HCPs who had received booster doses acquired a COVID-19 infection. Conclusion: It was found that prior COVID-19 infection and vaccination do not confer immunity from infection. However, proper vaccination limits the severity, morbidity, and mortality of COVID-19 infection.
引用
收藏
页数:4
相关论文
共 18 条
  • [1] Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers
    Alishaq, Moza
    Nafady-Hego, Hanaa
    Jeremijenko, Andrew
    Al Ajmi, Jameela Ali
    Elgendy, Mohamed
    Vinoy, Suni
    Fareh, Sameera Bihi
    Plaatjies, Justine Veronica
    Nooh, Mariam
    Alanzi, Nadya
    Kaleeckal, Anvar H.
    Latif, Ali Nizar
    Coyle, Peter
    Elgendy, Hamed
    Abou-Samra, Abdul-Badi
    Butt, Adeel Ajwad
    [J]. PLOS ONE, 2021, 16 (10):
  • [2] [Anonymous], 2021, COVID 19 VACCINE BRE
  • [3] [Anonymous], 2021, EFFECTS VIRUS VARIAN
  • [4] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
    Baden, Lindsey R.
    El Sahly, Hana M.
    Essink, Brandon
    Kotloff, Karen
    Frey, Sharon
    Novak, Rick
    Diemert, David
    Spector, Stephen A.
    Rouphael, Nadine
    Creech, C. Buddy
    McGettigan, John
    Khetan, Shishir
    Segall, Nathan
    Solis, Joel
    Brosz, Adam
    Fierro, Carlos
    Schwartz, Howard
    Neuzil, Kathleen
    Corey, Larry
    Gilbert, Peter
    Janes, Holly
    Follmann, Dean
    Marovich, Mary
    Mascola, John
    Polakowski, Laura
    Ledgerwood, Julie
    Graham, Barney S.
    Bennett, Hamilton
    Pajon, Rolando
    Knightly, Conor
    Leav, Brett
    Deng, Weiping
    Zhou, Honghong
    Han, Shu
    Ivarsson, Melanie
    Miller, Jacqueline
    Zaks, Tal
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) : 403 - 416
  • [5] Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
    Bergwerk, Moriah
    Gonen, Tal
    Lustig, Yaniv
    Amit, Sharon
    Lipsitch, Marc
    Cohen, Carmit
    Mandelboim, Michal
    Gal Levin, Einav
    Rubin, Carmit
    Indenbaum, Victoria
    Tal, Ilana
    Zavitan, Malka
    Zuckerman, Neta
    Bar-Chaim, Adina
    Kreiss, Yitshak
    Regev-Yochay, Gili
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) : 1474 - 1484
  • [6] Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
    Fiolet, Thibault
    Kherabi, Yousra
    MacDonald, Conor-James
    Ghosn, Jade
    Peiffer-Smadja, Nathan
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (02) : 202 - 221
  • [7] Vaccine Breakthrough Infections with SARS-CoV-2 Variants
    Hacisuleyman, Ezgi
    Hale, Caryn
    Saito, Yuhki
    Blachere, Nathalie E.
    Bergh, Marissa
    Conlon, Erin G.
    Schaefer-Babajew, Dennis J.
    DaSilva, Justin
    Muecksch, Frauke
    Gaebler, Christian
    Lifton, Richard
    Nussenzweig, Michel C.
    Hatziioannou, Theodora
    Bieniasz, Paul D.
    Darnell, Robert B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23) : 2212 - 2218
  • [8] Positive RT-PCR Test Results in 420 Patients Recovered From COVID-19 in Wuhan: An Observational Study
    He, Shaobin
    Tian, Jiaxing
    Li, Xiaodong
    Zhou, Yana
    Xiao, Mingzhong
    Zhang, Ying
    Min, Xiaojun
    Li, Xiuyang
    Jin, De
    Zhang, Qing
    Zheng, Yujiao
    Ke, Jia
    Li, Qingwei
    Tao, Junxiu
    Song, Ping
    Wang, Han
    Lv, Yi
    Ding, Qiyou
    Tang, Shuang
    Lin, Jiaran
    Jiang, Zhaoyuan
    Zhang, Zijun
    Song, Juexian
    Lian, Fengmei
    Tong, Xiaolin
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [9] SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
    Khan, Abbas
    Khan, Taimoor
    Ali, Shughla
    Aftab, Summiya
    Wang, Yanjing
    Qiankun, Wang
    Khan, Mazhar
    Suleman, Muhammad
    Ali, Shahid
    Heng, Wang
    Ali, Syed Shujait
    Wei, Dong-Qing
    Mohammad, Anwar
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2021, 143
  • [10] Maroof S., 2021, PAFMJ, V71, P1471